# Veylix — Current State & Checkpoint Tracker

This file tracks the active progress of the Veylix platform development across all sessions.

---

## Current Status

- **Completed Stage**: ETAPA 7 — Testing Hardening
- **Completed Checkpoint**: CHECKPOINT F — Jules Test Suite Review (APPROVED)
  - Jules Task: `14427223065886914327` / PR `#7`
  - Review Summary:
    1. Independent quality assurance and test suite review approved with zero defects.
    2. Verified complete mapping of invariants `INV-001` through `INV-007`.
    3. Verified `fast-check` property-based testing determinism and performance.
    4. Verified full RBAC security matrix, session security, and concurrency locking behavior.
    5. Confirmed full DoD suite compliance across all workspaces (179 tests passing).
- **Next Stage**: ETAPA 8 — Production Hardening
- **Next Checkpoint**: CHECKPOINT G — Jules Production Readiness Review

---

## Roadmap & Checkpoints Progress

- [x] **ETAPA 0: Discovery + Architecture** (Commit `15032bf`)
- [x] **CHECKPOINT A: Jules Architecture Review** (Merged in `f804d7c`)
- [x] **ETAPA 1: Foundation** (Commit `8344fb2`)
- [x] **ETAPA 2: Design System + Application Shell** (Commit `7a7e4a7`)
- [x] **CHECKPOINT B: Jules Frontend Review** (Merged in `11a01ea`)
- [x] **ETAPA 3: Domain + Database** (Commit `682f625`)
- [x] **CHECKPOINT C: Jules Domain & Database Review** (Merged in `cba0908`)
- [x] **ETAPA 4: Authentication + Authorization** (Commit `fcb6108`)
- [x] **CHECKPOINT D: Jules Security Review (Offensive)** (Merged in `fcb6108`)
- [x] **ETAPA 5: Core Asset Management** (Merged in `1f9283f`)
- [x] **ETAPA 6: Maintenance + Audit + Observability** (Commit `70a43b5`)
- [x] **CHECKPOINT E: Jules Production Readiness & Observability Audit** (Commit `b04f581`)
- [x] **ETAPA 7: Testing Hardening** (Commit `33ee9f2`)
- [x] **CHECKPOINT F: Jules Test Suite Review** (Merged in `1e19864`)
- [ ] **ETAPA 8: Production Hardening**
- [ ] **CHECKPOINT G: Jules Production Readiness Review**
- [ ] **ETAPA 9: Final Review (`docs/final-review.md`)**
